Form 4 for TNGX Tango Therapeutics, Inc.
Accepted 2026-03-09 00:00:00 ET · period of report 2026-03-05 · accession 0001193125-26-098443 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-03-09 | 2026-03-05 | TNGX | Crystal Adam | Pres, R, D | S - Sale | $15.00 | -20.3K | 112.6K | -15% | -$303.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-05 | S | D | 20,251 | $15.00 | 112,622 | D | — | — |